Parnassus Investments CA reduced its holdings in shares of Perrigo Company PLC (NYSE:PRGO) by 44.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,100,000 shares of the company’s stock after selling 897,500 shares during the quarter. Parnassus Investments CA owned 0.81% of Perrigo worth $42,625,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in PRGO. LS Investment Advisors LLC lifted its stake in Perrigo by 5.9% in the fourth quarter. LS Investment Advisors LLC now owns 4,317 shares of the company’s stock valued at $167,000 after buying an additional 239 shares during the last quarter. Atlas Capital Advisors LLC bought a new stake in Perrigo in the fourth quarter valued at $26,000. Penserra Capital Management LLC increased its holdings in shares of Perrigo by 16.5% during the third quarter. Penserra Capital Management LLC now owns 6,900 shares of the company’s stock valued at $488,000 after purchasing an additional 975 shares during the period. Cullen Frost Bankers Inc. increased its holdings in shares of Perrigo by 1.2% during the third quarter. Cullen Frost Bankers Inc. now owns 92,064 shares of the company’s stock valued at $6,518,000 after purchasing an additional 1,048 shares during the period. Finally, Stone Ridge Asset Management LLC increased its holdings in shares of Perrigo by 11.3% during the third quarter. Stone Ridge Asset Management LLC now owns 14,746 shares of the company’s stock valued at $1,044,000 after purchasing an additional 1,500 shares during the period. Institutional investors own 85.72% of the company’s stock.
A number of research analysts have recently commented on the company. Berenberg Bank lowered Perrigo from a “buy” rating to a “hold” rating and lowered their price target for the company from $100.00 to $72.00 in a report on Tuesday, November 13th. ValuEngine raised Perrigo from a “strong sell” rating to a “sell” rating in a report on Friday, November 16th. Royal Bank of Canada set a $63.00 price target on Perrigo and gave the company a “hold” rating in a report on Friday, November 9th. Morgan Stanley lowered their target price on Perrigo from $77.00 to $67.00 and set a “hold” rating on the stock in a report on Tuesday, November 13th. Finally, Wells Fargo & Co set a $46.00 target price on Perrigo and gave the stock a “hold” rating in a report on Sunday, December 30th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $77.36.
COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4146448/perrigo-company-plc-prgo-shares-sold-by-parnassus-investments-ca.html.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Recommended Story: What is the price-sales ratio?
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company PLC (NYSE:PRGO).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.